Search Weight Loss Topics:




Jul 28

Which Weight Loss Drug Should You Choose (if You Get to Choose)? – The New York Times

Lose Weight Comments Off on Which Weight Loss Drug Should You Choose (if You Get to Choose)? – The New York Times

People with obesity now have a choice between two powerful drugs to help them lose weight. One is semaglutide, sold by Novo Nordisk as Wegovy for obesity treatment and as Ozempic for diabetes. The second, tirzepatide, is sold by Eli Lilly as Zepbound for obesity and as Mounjaro for diabetes. Many with neither obesity or diabetes take the drugs to get thinner.

A recent study suggested that people lost more weight taking Mounjaro than they did taking Ozempic, and it may leave you wondering: Which should I take? And if Im already taking one of them, should I switch?

The answers, obesity medicine experts say, are not so simple. Here are some factors that can help sort out hype from realistic hope.

For now, its hard to say. All of the information available comes from highly flawed studies, said Dr. Diana Thiara, medical director of the weight loss clinic at the University of California, San Francisco.

That includes the recent study comparing Mounjaro and Ozempic. Using electronic health records, the researchers reported that those taking Mounjaro lost an average of 15.3 percent of their weight after a year. Those taking Ozempic lost an average of 8.3 percent.

While that sounds impressive, Dr. Susan Z. Yanovski, co-director of the Office of Obesity Research at the National Institute of Diabetes and Digestive and Kidney Diseases, said, I wouldnt make any decisions on my medical care based solely on a study like this.

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit andlog intoyour Times account, orsubscribefor all of The Times.

Thank you for your patience while we verify access.

Already a subscriber?Log in.

Want all of The Times?Subscribe.

Go here to read the rest:
Which Weight Loss Drug Should You Choose (if You Get to Choose)? - The New York Times

Related Posts

    Your Full Name

    Your Email

    Your Phone Number

    Select your age (30+ only)

    Select Your US State

    Program Choice

    Confirm over 30 years old

    Yes

    Confirm that you resident in USA

    Yes

    This is a Serious Inquiry

    Yes

    Message:



    matomo tracker